BioPharma Credit - Edison Group

Popular Searches:

Your Previous Searches:

Recently Visited Pages:

Home
Sparks
Equities
Equities
View All Equities
Equities by Sector

Consumer

Energy & Resources

Financials

Healthcare

Industrials

Investment Companies

Metals & Mining

Real Estate

TMT

Chosa

MCap

SEK50m

Last close

SEK0.95

▲ 0.25 (35.71%)

Metals One

MCap

GBP4m

Last close

GBP0.01

▲ 0.18 (19.44%)

Quadrise

MCap

GBP86m

Last close

GBP0.05

▲ 0.55 (12.66%)
Sectors
Sectors
Thematics
Thematics
View All Thematics

Latest
Audiovisual
Audiovisual
View All Audiovisual

Latest

Events
About Edison
About Edison
About Edison

Careers

“Edison’s accessible and high-quality research gives us the opportunity to communicate an independent perspective of Tyman to a wide variety of potential stakeholders.”

Financial Director
Equity Research
Investor Relations
Contact us

Overview
Research
Thematics

Latest Insights

View More

Investment Companies |
Review

03.11.22

Biopharma Credit — A quality dividend play with FY22 yield of 12%

Investment Companies |
edison tv

29.09.22

BioPharma Credit – executive interview

Investment Companies |
Update

16.03.22

Biopharma Credit — New transaction of up to US$50m

Investment Companies |
Update

10.01.22

Biopharma Credit — Fully invested after recent transactions

Sector

Investment Companies

Research

Review

Investment Companies

14.11.19

Biopharma Credit — Invests in Epizyme and Akebia

edison tv

Investment Companies

06.11.19

Bitesize briefing – BioPharma Credit

Investment Companies

Review

Biopharma Credit — High investment volume in H219

Review

Investment Companies

30.09.19

BioPharma Credit — New debt investment in OptiNose

Review

Investment Companies

03.06.19

BioPharma Credit — Debt and equity investment in BDSI

Review

Investment Companies

06.11.18

Biopharma Credit — Oversubscribed offering fuels further growth

Update

Investment Companies

17.05.18

Biopharma Credit — Leading lender in life sciences

thematic

Investment Companies

31.07.24

US small-cap equities – Time to shine?

thematic

Investment Companies

10.06.24

Emerging markets – Worthy of consideration

thematic

Investment Companies

06.06.24

Dynam Capital at the 2024 Vietnam ESG Conference

thematic

Investment Companies

16.05.24

UK stock market – Scope for further upside in UK large-cap stocks

thematic

Investment Companies

06.03.24

Listed private equity – Performing a balancing act

thematic

Investment Companies

13.02.23

European equities

thematic

Investment Companies

08.02.23

Listed Private Equity

thematic

Investment Companies

27.01.23

Vietnamese equities: Due a comeback?

thematic

Investment Companies

30.11.22

Investment companies: Latin America is worthy of consideration

thematic

Consumer

05.10.22

IPO apocalypse

thematic

TMT

10.08.22

ESG, moving beyond the box tick

thematic

Investment Companies

10.05.22

The case for US capital markets

thematic

Investment Companies

07.12.20

Value Investing: Living with the reality, waiting for the inevitable

thematic

Consumer

14.08.19

Illuminator: August Update

thematic

Investment Companies

07.08.19

Post Woodford- A spotlight on smaller company liquidity

thematic

Investment Companies

05.06.19

How to buy and sell investment trusts

thematic

Investment Companies

26.03.19

Types of investment trusts

thematic

Consumer

11.11.14

Deutsche Börse Eigenkapitalforum 2014 Research Guide

thematic

Investment Companies

24.05.12

Investment Trusts Quarterly: Biotechnology & healthcare trusts

thematic

Investment Companies

13.01.12

Investment Trusts Quarterly: Growth and income